These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 18556207)

  • 21. Prion inhibition with multivalent PrPSc binding compounds.
    Mays CE; Joy S; Li L; Yu L; Genovesi S; West FG; Westaway D
    Biomaterials; 2012 Oct; 33(28):6808-22. PubMed ID: 22748770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
    May BC; Fafarman AT; Hong SB; Rogers M; Deady LW; Prusiner SB; Cohen FE
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3416-21. PubMed ID: 12626750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position.
    Nguyen T; Sakasegawa Y; Doh-Ura K; Go ML
    Eur J Med Chem; 2011 Jul; 46(7):2917-29. PubMed ID: 21531054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similar structure-activity relationships of quinoline derivatives for antiprion and antimalarial effects.
    Klingenstein R; Melnyk P; Leliveld SR; Ryckebusch A; Korth C
    J Med Chem; 2006 Aug; 49(17):5300-8. PubMed ID: 16913719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiprion activity of functionalized 9-aminoacridines related to quinacrine.
    Nguyen TH; Lee CY; Teruya K; Ong WY; Doh-ura K; Go ML
    Bioorg Med Chem; 2008 Jul; 16(14):6737-46. PubMed ID: 18556207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell culture models to unravel prion protein function and aberrancies in prion diseases.
    Bedecs K
    Methods Mol Biol; 2008; 459():1-20. PubMed ID: 18576144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acridine-a neglected antibacterial chromophore.
    Wainwright M
    J Antimicrob Chemother; 2001 Jan; 47(1):1-13. PubMed ID: 11152426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiprion drugs as chemical tools to uncover mechanisms of prion propagation.
    Tribouillard D; Gug F; Galons H; Bach S; Saupe SJ; Blondel M
    Prion; 2007; 1(1):48-52. PubMed ID: 19164923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prions: protein aggregation and infectious diseases.
    Aguzzi A; Calella AM
    Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.